Company profile: Ception Therapeutics
1.1 - Company Overview
Company description
- Provider of payroll management services, delivering customizable payroll solutions and advanced software for seamless, timely processing; comprehensive administration covering tax filings and employee deductions; payroll compliance with the latest laws and regulations; and consulting on best practices and audit assistance, allowing businesses to focus on growth.
Products and services
- Payroll Processing: Software-based service that executes payroll seamlessly and on time using advanced software, ensuring efficient operations across pay periods
- Payroll Compliance: Regulatory-compliant oversight that ensures payroll adheres to the latest laws and regulations, keeping operations aligned with current statutory requirements
- Payroll Solutions: Customizable products architected to meet the specific needs of different businesses, enabling tailored payroll options per organization for focused fit
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Ception Therapeutics
AB2 Bio
HQ: Switzerland
Website
- Description: Provider of drug discovery and development of best-in-class therapies for inflammatory diseases, including Tadekinig alfa, a recombinant IL-18 binding protein restoring the IL-18/IL-18BP balance; a proprietary assay to detect and measure free IL-18; and clinical programs in primary HLH (Phase III), secondary HLH/MAS, and adult-onset Still's disease (Phase II).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AB2 Bio company profile →
OMass Therapeutics
HQ: United Kingdom
Website
- Description: Provider of drug discovery leveraging novel mass spectrometry, offering the OdyssION platform that uses native mass spectrometry and custom chemistry to study target interactions in native ecosystems, and a small molecule pipeline targeting solute carriers, inflammasome complexes, and GPCRs for orphan and immunological diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OMass Therapeutics company profile →
Vera Therapeutics
HQ: United States
Website
- Description: Provider of biologic therapeutics, including atacicept, a recombinant fusion protein containing the soluble TACI receptor that binds the cytokines BAFF and APRIL, used to treat IgA nephropathy and lupus nephritis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vera Therapeutics company profile →
Viela Bio
HQ: United States
Website
- Description: Provider of clinical-stage treatments for severe inflammation and autoimmune diseases, with a portfolio that selectively targets shared critical pathways at the root cause of disease; led by global leaders in inflammation and autoimmunity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Viela Bio company profile →
Protalex
HQ: United States
Website
- Description: Provider of a class of biopharmaceutical drugs designed to treat autoimmune and inflammatory; a development stage company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Protalex company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Ception Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Ception Therapeutics
2.2 - Growth funds investing in similar companies to Ception Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Ception Therapeutics
4.2 - Public trading comparable groups for Ception Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →